Annual Review 2008

Many of the drug classes which are included in the prior authorization program are reviewed each fiscal year.  These reports include detailed statistics on utilization, prior authorization, market share, new products, and other notable events for the category during the previous year.  These reports were not included on a DUR Board agenda and are in addition to the utilization reports included with the DUR Board packets.

2008

Amitiza

Elidel_Protopic 

Glumetza Fortamet 

Muscle Relaxants 

NSAID's 

Propoxyphene 

Smoking Cessation 

Tramadol Products 

Xolair 

Xopenex